Skip to content

Wednesday, December 18, 2024

Latest:

Mapping functional relations among proteins and genes helps illuminate their role in cancer
Occupational therapy: what patients need to know
Holly jolly health tips for Santa (and you)
Championing better care for adolescents with iron deficiency: Highlighting the impact of quality improvement initiatives
SPACe: A new open-source platform that supports large imaging data analysis on standard computers

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

PI3K inhibitor

Targeting MAPK4 may offer a new therapeutic opportunity for TNBC

January 27, 2022 AKT, cancer therapy, MAPK4, PI3K, PI3K inhibitor, Research, triple-negative breast cancer

MAPK4 seems to be involved in promoting triple-negative breast cancer growth and its resistance to certain therapies.

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951